Percutaneous Coronary Intervention (High-risk PCI) clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • ELEVATE High-Risk PCI Pivotal Study

    open to eligible people ages 18-88

    The ELEVATE III Pivotal Study is a prospective, multi-center, open-label, interventional, randomized, controlled study with an active control group. The study is intended to assess the safety and efficacy of the Elevate™ percutaneous Left Ventricular Assist Device System in patients referred to high-risk percutaneous coronary interventions (HR-PCI).

    at UCSF

Our lead scientists for Percutaneous Coronary Intervention (High-risk PCI) research studies include .

Last updated: